Applied Therapeutics Ownership | Who Owns Applied Therapeutics?
Applied Therapeutics Ownership Summary
Applied Therapeutics is owned by 780.92% institutional investors, 5.24% insiders. Franklin resources is the largest institutional shareholder, holding 8.15% of APLT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.71% of its assets in Applied Therapeutics shares.
APLT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Applied Therapeutics | 780.92% | 5.24% | -686.15% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Franklin resources | 10.21M | 8.15% | $47.69M |
| Vr adviser | 9.54M | 7.61% | $44.57M |
| Janus henderson group | 7.65M | 6.10% | $35.49M |
| Blackrock | 6.57M | 5.24% | $30.68M |
| Propel bio management | 6.57M | 5.24% | $30.67M |
| Knoll capital management | 5.57M | 4.45% | $26.03M |
| Vestal point capital, lp | 5.43M | 4.33% | $25.36M |
| Vanguard group | 5.32M | 4.25% | $24.86M |
| Morgan stanley | 3.52M | 2.81% | $16.44M |
| Simplify asset management | 2.82M | 2.25% | $13.16M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Propel bio management | 6.57M | 19.89% | $30.67M |
| Knoll capital management | 5.57M | 17.54% | $26.03M |
| Stempoint capital lp | 2.21M | 3.03% | $10.33M |
| Vr adviser | 9.54M | 2.84% | $44.57M |
| Vestal point capital, lp | 5.43M | 1.89% | $25.36M |
| Opaleye management | 1.68M | 1.79% | $7.85M |
| Tang capital management | 2.33M | 1.11% | $10.88M |
| Simplify asset management | 2.82M | 0.88% | $13.16M |
| Parkman healthcare partners | 1.15M | 0.72% | $5.36M |
| Soleus capital management | 1.27M | 0.52% | $5.93M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 6.57M | 0.00% | 5.58M |
| Vanguard group | 5.32M | 0.00% | 2.31M |
| Deutsche bank ag\ | 2.34M | 0.00% | 1.72M |
| Geode capital management | 2.10M | 0.00% | 1.49M |
| State street | 1.66M | 0.00% | 1.45M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Alyeska investment group | - | - | -4.00M |
| Frazier life sciences management | - | - | -2.29M |
| Laurion capital management lp | 50.00K | 0.00% | -1.43M |
| Schonfeld strategic advisors | 533.73K | 0.02% | -1.30M |
| Millennium management | 110.91K | 0.00% | -815.52K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Peregrine capital management | 731.05K | 0.10% | 731.05K | $3.41M |
| Nuveen asset management | 271.61K | 0.00% | 271.61K | $1.27M |
| Hennion & walsh asset management | 197.04K | 0.05% | 197.04K | $920.19K |
| Sei investments | 114.62K | 0.00% | 114.62K | $535.27K |
| Alps advisors | 89.13K | 0.00% | 89.13K | $416.24K |
Sold Out
| Holder | Change |
|---|---|
| Newedge advisors | -199.00 |
| Tower research capital llc (trc) | -10.26K |
| Ctc alternative strategies | -10.40K |
| Raymond james & associates | -10.66K |
| Gsa capital partners llp | -10.92K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 143 | 41.58% | 112,721,880 | 9.20% | 780 | 11.51% | 85 | 37.10% | 33 | 37.50% |
| Jun 30, 2024 | 101 | 1.00% | 103,226,978 | 9.86% | 82 | 1.47% | 62 | -7.46% | 24 | 50.00% |
| Mar 31, 2024 | 100 | 12.36% | 93,965,703 | 53.04% | 74 | 1.41% | 67 | 15.52% | 16 | 45.45% |
| Dec 31, 2023 | 89 | 56.14% | 61,400,847 | 42.94% | 72 | 3.25% | 58 | 70.59% | 11 | 57.14% |
| Sep 30, 2023 | 57 | 32.56% | 42,956,878 | 36.52% | 47 | 2.99% | 34 | 70.00% | 7 | -22.22% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.16M | 2.71% | 4.60K |
| Simplify Propel Opportunities ETF | 2.82M | 2.42% | - |
| Franklin Biotechnology Discv A(acc)USD | 2.63M | 2.26% | -1.68M |
| Franklin Biotechnology Discovery A | 2.49M | 2.17% | -717.00K |
| iShares Russell 2000 ETF | 2.49M | 2.14% | -5.59K |
| SPDR® S&P Biotech ETF | 1.76M | 1.53% | 19.44K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.15M | 0.99% | -3.85K |
| Fidelity Small Cap Index | 984.01K | 0.86% | -25.59K |
| Janus Henderson Hrzn Biotec E2 USD | 762.22K | 0.66% | 202.19K |
| Xtrackers S&P 500 Swap ETF 1C | 622.23K | 0.53% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 22, 2024 | Funtleyder Leslie D. | Chief Financial Officer | Sell | $78.88K |
| Aug 22, 2024 | Perfetti Riccardo | Chief Medical Officer | Sell | $132.23K |
| Aug 13, 2024 | Shendelman Shoshana | President and CEO | Sell | $2.21M |
| Aug 14, 2024 | Shendelman Shoshana | President and CEO | Sell | $709.17K |
| Aug 12, 2024 | Shendelman Shoshana | President and CEO | Sell | $1.79M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 5 |
| 2024 Q1 | - | 4 |
| 2023 Q4 | 1 | 7 |
| 2023 Q3 | - | 3 |
APLT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools